Patents by Inventor Gabriel Bitton
Gabriel Bitton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240066228Abstract: A drug tracking device used in combination with a drug injection device. The drug tracking device may comprise a housing configured to engage with the drug injection device, an optical sensor configured to capture an image of a portion of the drug injection device. The portion of the drug injection device displays indicia of drug doses, such that a captured image includes at least one indicia of a drug dose. The drug tracking device may include a memory module having pre-stored indicia of drug doses, and a processor having instructions operating thereon configured to cause the processor to determine an injected drug dose by comparing at least one indicia of the drug dose in the captured image with the pre-stored indicia of drug doses.Type: ApplicationFiled: October 24, 2023Publication date: February 29, 2024Inventors: Gabriel BITTON, Ephraim OVED, Avi BEN-SIMON
-
Patent number: 11833333Abstract: A drug tracking device used in combination with a drug injection device. The drug tracking device may comprise a housing configured to engage with the drug injection device, an optical sensor configured to capture an image of a portion of the drug injection device. The portion of the drug injection device displays indicia of drug doses, such that a captured image includes at least one indicia of a drug dose. The drug tracking device may include a memory module having pre-stored indicia of drug doses, and a processor having instructions operating thereon configured to cause the processor to determine an injected drug dose by comparing at least one indicia of the drug dose in the captured image with the pre-stored indicia of drug doses.Type: GrantFiled: July 12, 2018Date of Patent: December 5, 2023Assignee: Insuline Medical LTDInventors: Gabriel Bitton, Ephraim Oved, Avi Ben-Simon
-
Publication number: 20210085876Abstract: A drug tracking device used in combination with a drug injection device. The drug tracking device may comprise a housing configured to engage with the drug injection device, an optical sensor configured to capture an image of a portion of the drug injection device. The portion of the drug injection device displays indicia of drug doses, such that a captured image includes at least one indicia of a drug dose. The drug tracking device may include a memory module having pre-stored indicia of drug doses, and a processor having instructions operating thereon configured to cause the processor to determine an injected drug dose by comparing at least one indicia of the drug dose in the captured image with the pre-stored indicia of drug doses.Type: ApplicationFiled: July 12, 2018Publication date: March 25, 2021Inventors: Gabriel BITTON, Ephraim OVED, Avi BEN-SIMON
-
Patent number: 10842943Abstract: Embodiments of the present disclosure present systems, methods and devices related to the tracking of drugs injected by injection devices. For example, in some embodiments, a drug dispensing-tracking device for use in combination with a drug-injection device is provided, where the device comprises a sleeve configured to connect with at least one mechanical feature provided on the injection device, a battery, at least one sensor, an electrical circuit for analog or digital short range communication, and a transmission element. In some embodiments, for each injection, the sensor is configured to automatically detect at least one of an auditory signal, movement, and optical signal, and an auditory signal is generated by at least one of the setting of the injection device for dispensing a drug, the dispensing action of the injection device, and the flow of the drug out of the injection device.Type: GrantFiled: February 28, 2019Date of Patent: November 24, 2020Assignee: INSULINE MEDICAL LTD.Inventors: Ron Nagar, Gabriel Bitton, Moshe Fadlun
-
Patent number: 10743170Abstract: A device, system and method for emergency audio transmission is provided. A server receives, over a broadband network, a request to make an emergency audio transmission to a talk group. The request is received from a first push-to-talk (PTT) device communicatively connected with the talk group over a narrow band network at which a second PTT device of the talk group has floor control. In response to granting the request, the server receives, from the first PTT device, an audio transmission over the broadband network, and transmits the audio transmission to the talk group via the broadband network.Type: GrantFiled: November 28, 2019Date of Patent: August 11, 2020Assignee: MOTOROLA SOLUTIONS, INC.Inventors: Mordechai Glick, Gabriel Bitton, Nissim Gean, Alexander Massover, Sapir Blutman
-
Patent number: 10569028Abstract: A drug dispensing-tracking device configured in the form of at least one of a cover, a sleeve, and a cap, and configured to connect with a drug-injection or storage device. The tracking device may comprise at least one or more of: an acoustic sensor, a vibration sensor, an optical sensor, an optical-navigation sensor, and a magnetic sensor, and any combination thereof. At least one sensor may be configured to produce at least one respective signal in response to sensing a vibration, a sound, light, movement, and a magnetic field, respectively, produced by the drug-injection device due to an activity of the drug-injection device.Type: GrantFiled: November 5, 2015Date of Patent: February 25, 2020Inventors: Gabriel Bitton, Gal Ben-David
-
Publication number: 20200038600Abstract: A drug delivery control apparatus (e.g. a treatment apparatus) may be configured to control an amount of drug contained in a drug depot delivered or otherwise perfused or diffused into the circulatory system of a patient comprising a cooling element configured for cooling a treatment area by removing heat from the treatment area. The cooling element may be arranged above or near the treatment area. A heat disposal assembly is in thermal communication with the cooling element and configured for directing the removed heat to a heat zone away from the treatment area. A power source, a controller and a housing may be configured to at least partially house at least the cooling element and the heat disposal assembly.Type: ApplicationFiled: October 5, 2017Publication date: February 6, 2020Inventors: Gabriel BITTON, Avi BEN-SIMON
-
Publication number: 20190192779Abstract: Embodiments of the present disclosure present systems, methods and devices related to the tracking of drugs injected by injection devices. For example, in some embodiments, a drug dispensing-tracking device for use in combination with a drug-injection device is provided, where the device comprises a sleeve configured to connect with at least one mechanical feature provided on the injection device, a battery, at least one sensor, an electrical circuit for analog or digital short range communication, and a transmission element. In some embodiments, for each injection, the sensor is configured to automatically detect at least one of an auditory signal, movement, and optical signal, and an auditory signal is generated by at least one of the setting of the injection device for dispensing a drug, the dispensing action of the injection device, and the flow of the drug out of the injection device.Type: ApplicationFiled: February 28, 2019Publication date: June 27, 2019Inventors: Ron Nagar, Gabriel Bitton, Moshe Fadlun
-
Publication number: 20180280624Abstract: A drug dispensing-tracking device configured in the form of at least one of a cover, a sleeve, and a cap, and configured to connect with a drug-injection or storage device. The tracking device may comprise at least one or more of: an acoustic sensor, a vibration sensor, an optical sensor, an optical-navigation sensor, and a magnetic sensor, and any combination thereof. At least one sensor may be configured to produce at least one respective signal in response to sensing a vibration, a sound, light, movement, and a magnetic field, respectively, produced by the drug-injection device due to an activity of the drug-injection device.Type: ApplicationFiled: November 5, 2015Publication date: October 4, 2018Applicant: INSULINE MEDICAL LTD.Inventors: Gabriel BITTON, Gal BEN-DAVID
-
Patent number: 9808577Abstract: The present invention relates to a device, system and a method for optimizing syringe based drug delivery profile with a treatment element and in particular, to such a device, system and method in which optimization is based on a plurality of data that directly and/or indirectly affect the optimization of the drug delivery profile. The device facilitating syringe based drug delivery, by optimizing drug delivery of the injected drug, records user's activity, and data relative to drug injections, comprising a disposable unit configured for a single use period and a rechargeable reusable unit having electronics comprising a sensor module.Type: GrantFiled: May 10, 2012Date of Patent: November 7, 2017Assignee: Insuline Medical Ltd.Inventors: Ron Nagar, Gabriel Bitton, Elisha Amir, Moshe Fadlun
-
Patent number: 9731084Abstract: A therapeutic treatment device, system and method for improving administration of a temperature sensitive drug into a tissue on the body of a patient at a drug injection site are disclosed. The device includes a treatment element with a controllable heating element in temperature communicative contact with the tissue adjacent to the drug injection site. The controllable heating element is configured to heat the tissue adjacent to the drug injection site to a controllable temperature but does not heat the injected drug above a predetermined limiting temperature, above which degradation of the injected drug may occur.Type: GrantFiled: January 29, 2015Date of Patent: August 15, 2017Assignee: Insuline Medical Ltd.Inventors: Benny Pesach, Gabriel Bitton, Ron Nagar, Ram Weiss
-
Patent number: 9526826Abstract: A device and method for delivering a therapeutic substance to the body of a mammal may include a pump adapter, a pump, and an infusion set having a distal connector and a proximal connector. The proximal connector and the pump adapter have connecting electrical contacts which can be connected to one another in a single action when the proximal connector and pump are being secured to the pump adapter. The distal connector of the infusion set can be connected to a catheter housing, which can be secured to the mammal's skin. The distal connector and the catheter housing have additional connecting electrical contacts which can be connected to one another in a single action when connecting the distal connector to the catheter housing.Type: GrantFiled: May 16, 2012Date of Patent: December 27, 2016Assignee: INSULINE MEDICAL LTD.Inventors: Ron Nagar, Gabriel Bitton, Elisha Amir
-
Publication number: 20160302707Abstract: The present invention relates to a device, system and a method for measuring an analyte and in particular, to such a device, system and method in which analyte from a bodily fluid is measured and/or monitored.Type: ApplicationFiled: November 16, 2015Publication date: October 20, 2016Inventors: Benny Pesach, Gabriel Bitton, Ron Nagar
-
Publication number: 20160166777Abstract: Embodiments of the present disclosure present systems, methods and devices relate to regulating drug absorption in a body of a patient, including delivering a dose of long-acting drug at a delivery site of a patient, applying a treatment to a treatment area surrounding and including the delivery site. A substantial portion of the drug may reside in tissue adjacent the treatment area for an extended period of time and may include a drug depot. The treatment may be configured to modify the level of at least one property of at least a portion of the treatment area. The absorption rate of the long-acting drag from the drug depot changes according to the level of the property.Type: ApplicationFiled: July 3, 2014Publication date: June 16, 2016Inventors: Gabriel BITTON, Ron NAGAR
-
Publication number: 20160022905Abstract: Embodiments of the present disclosure present systems, methods and devices relate to delivering a drug subcutaneously to a patient. For example, a subcutaneous drug delivery device for use in delivering a drug subcutaneously to a patient can include a needle or cannula configured for delivery of a drug from a drug reservoir to a subcutaneous tissue of a patient.Type: ApplicationFiled: March 4, 2014Publication date: January 28, 2016Applicant: Insuline Medical LtdInventors: Ron NAGAR, Gabriel BITTON
-
Patent number: 9220837Abstract: A method and a device for a delivery of a chemical substance to the body of the patient are provided. The device includes an infusion catheter configured to be inserted into a tissue, a catheter securing element configured to be adhered to the skin of the patient and further configured to secure the infusion catheter to the skin, a drug delivery pump configured to infuse a drug into the infusion catheter for delivery to a drug infused region on the body of the patient, and a treatment element configured to apply a treatment to the drug infused region to improve pharmacodynamics of the drug during a period of delivery of the drug to the patient.Type: GrantFiled: June 21, 2007Date of Patent: December 29, 2015Assignee: INSULINE MEDICAL LTD.Inventors: Benny Pesach, Ron Nagar, Gabriel Bitton, Ram Weiss
-
Publication number: 20150314063Abstract: Systems, methods and devices for delivering a therapeutic fluid into tissue are disclosed. The system includes an infusion set having a catheter for delivery of a dose of therapeutic fluid into a tissue via an infusion tube, a treatment element that applies treatment to the tissue proximate to the catheter, a catheter adaptor having a first transponder, a pump adaptor, in communication with the catheter adaptor, having a second transponder that communicates with the first transponder, and an infusion detection sensor that detects an infusion of the therapeutic fluid. Upon detection of an infusion of the therapeutic fluid by the infusion detection sensor, the second transponder communicates a signal indicative of the detected infusion to the first transponder causing the catheter adaptor to apply treatment using the treatment element. At least one of a strength and a duration of the treatment corresponds to a dose of the infused therapeutic fluid.Type: ApplicationFiled: December 6, 2013Publication date: November 5, 2015Inventors: Ron NAGAR, Gabriel BITTON
-
Publication number: 20150290396Abstract: Embodiments of the present disclosure present systems, methods and devices related to the tracking of drugs injected by injection devices. For example, in some embodiments, a drug dispensing-tracking device for use in combination with a drug-injection device is provided, where the device comprises a sleeve configured to connect with at least one mechanical feature provided on the injection device, a battery, at least one sensor, an electrical circuit for analog or digital short range communication, and a transmission element. In some embodiments, for each injection, the sensor is configured to automatically detect at least one of an auditory signal, movement, and optical signal, and an auditory signal is generated by at least one of the setting of the injection device for dispensing a drug, the dispensing action of the injection device, and the flow of the drug out of the injection device.Type: ApplicationFiled: October 22, 2013Publication date: October 15, 2015Inventors: Ron Nagar, Gabriel Bitton, Moshe Fadlun
-
Publication number: 20150265780Abstract: A therapeutic treatment device, system and method for improving administration of a temperature sensitive drug into a tissue on the body of a patient at a drug injection site are disclosed. The device includes a treatment element with a controllable heating element in temperature communicative contact with the tissue adjacent to the drug injection site. The controllable heating element is configured to heat the tissue adjacent to the drug injection site to a controllable temperature but does not heat the injected drug above a predetermined limiting temperature, above which degradation of the injected drug may occur.Type: ApplicationFiled: January 29, 2015Publication date: September 24, 2015Inventors: Benny Pesach, Gabriel Bitton, Ron Nagar, Ram Weiss
-
Patent number: D760374Type: GrantFiled: December 28, 2012Date of Patent: June 28, 2016Assignee: INSULINE MEDICAL LTD.Inventors: Ron Nagar, Gabriel Bitton, Elisha Amir, Gadi Amit, Barbara A. Stettler, Brandon Warren